Land: Israel
Sprog: engelsk
Kilde: Ministry of Health
PRASUGREL
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD
B01AC22
FILM COATED TABLETS
PRASUGREL 10 MG
PER OS
Required
GEDEON RICHTER ROMÂNIA S.A., ROMANIA
PRASUGREL
Prasugrel - Trima 10 mg, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI] undergoing primary or delayed percutaneous coronary intervention (PCI). The increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had TIA/CVA in the past and in those above the age of 75 or weight below 60 kg.
2023-06-04
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor’s prescription only Prasugrel - Trima 10 mg Film-coated tablets Active ingredient Each film-coated tablet contains: prasugrel 10 mg For information regarding inactive ingredients and allergens, see section 2 under “Important information about some of the ingredients of the medicine” and section 6 - “Additional information”. Read the entire leaflet carefully before using the medicine. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for your treatment. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. Prasugrel - Trima 10 mg is not intended for children and adolescents under the age of 18, since no information is available regarding the efficacy and safety of this medicine in this age group. 1. What is the medicine intended for? Prasugrel - Trima 10 mg in combination with acetylsalicylic acid is intended for prevention of atherothrombotic events in patients with acute coronary syndrome (unstable angina pectoris, acute myocardial infarction) who are undergoing primary or planned catheterization with or without a stent. Therapeutic class: platelet aggregation inhibitors. 2. Before using the medicine Do not use this medicine if: You are sensitive (allergic) to the active ingredient or to any of the additional ingredients the medicine contains (see section 6). An allergic reaction may occur as a rash, itch, swelling of the face and lips or shortness of breath. If you experience any of these effects, inform your doctor immediately. You have active bleeding (such as bleeding from an ulcer in your digestive system). You have previously had a stroke or a transient ischemic attack (TIA). You have severe liver disease. Special warnings regarding the use of the medicine Before treatment with Prasugrel - Trima, Læs hele dokumentet